{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:14:12Z","timestamp":1791180852671,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/hco.0b013e32834598fe","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T04:49:21Z","timestamp":1300337361000},"page":"190-195","source":"Crossref","is-referenced-by-count":63,"title":["The ubiquitin\u2013proteasome system in cardiomyopathies"],"prefix":"10.1097","volume":"26","author":[{"given":"Saskia","family":"Schlossarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.ph.49.030187.002533","article-title":"Biochemical mechanisms of cardiac hypertrophy","volume":"49","author":"Morgan","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","article-title":"The ubiquitin-proteasome system: focus on the heart","volume":"70","author":"Zolk","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbadis.2008.06.009","article-title":"The ubiquitin-proteasome system in cardiac dysfunction","volume":"1782","author":"Mearini","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/cdd.2009.27","article-title":"The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation","volume":"16","author":"Bello","year":"2009","journal-title":"Cell Death Differ"},{"key":"R5-4-20210204","first-page":"S760","article-title":"MYFbx, a novel cardiac-specific e3 ligase, is a component of the sarcomeric z-disk and mediates degradation of \u03b1-actinin and filamin c","volume":"120","author":"Busch","year":"2009","journal-title":"Circulation"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvp226","article-title":"Proteasome inhibitors and cardiac cell growth","volume":"85","author":"Hedhli","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1074\/mcp.M700187-MCP200","article-title":"Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities","volume":"6","author":"Drews","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvp217","article-title":"Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors","volume":"85","author":"Kloss","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.yexcr.2010.02.003","article-title":"Illuminating the ubiquitin\/proteasome system","volume":"316","author":"Salomons","year":"2010","journal-title":"Exp Cell Res"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cvr\/cvp362","article-title":"The role of the ubiquitin-proteasome pathway in cardiovascular disease","volume":"85","author":"Depre","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvp247","article-title":"The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy","volume":"85","author":"Carrier","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cvr\/cvp348","article-title":"Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms","volume":"85","author":"Mearini","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbrc.2005.12.120","article-title":"Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice","volume":"340","author":"Tsukamoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.yjmcc.2006.04.022","article-title":"Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases","volume":"41","author":"Balasubramanian","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.110.222364","article-title":"Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy","volume":"107","author":"Drews","year":"2010","journal-title":"Circ Res"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy: from genetics to treatment","volume":"40","author":"Marian","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.RES.82.1.130","article-title":"Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development","volume":"82","author":"Fougerousse","year":"1998","journal-title":"Circ Res"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.RES.82.1.124","article-title":"Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle","volume":"82","author":"Gautel","year":"1998","journal-title":"Circ Res"},{"key":"R20-4-20210204","first-page":"238","article-title":"Cardiac myosin-binding protein C in the heart","volume":"100","author":"Carrier","year":"2007","journal-title":"Arch Mal Coeur Vaiss"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","article-title":"Phosphorylation and function of cardiac myosin binding protein-C in health and disease","volume":"48","author":"Barefield","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI119555","article-title":"Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein","volume":"100","author":"Rottbauer","year":"1997","journal-title":"J Clin Invest"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.CIR.101.12.1396","article-title":"A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance","volume":"101","author":"Moolman","year":"2000","journal-title":"Circulation"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/jmbi.1999.3276","article-title":"COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and\/or incorporation in fetal rat cardiomyocytes","volume":"294","author":"Flavigny","year":"1999","journal-title":"J Mol Biol"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardiores.2005.01.004","article-title":"Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants","volume":"66","author":"Sarikas","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jmb.2008.09.070","article-title":"Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy","volume":"384","author":"Bahrudin","year":"2008","journal-title":"J Mol Biol"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.RES.85.9.841","article-title":"In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy","volume":"85","author":"Yang","year":"1999","journal-title":"Circ Res"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.109.904557","article-title":"Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies","volume":"121","author":"Predmore","year":"2010","journal-title":"Circulation"},{"key":"R31-4-20210204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","author":"Vignier","year":"2009","journal-title":"Circ Res"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/cvr\/cvp287","article-title":"The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective","volume":"85","author":"Su","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R33-4-20210204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/hrt.2004.040337","article-title":"New insights into the pathology of inherited cardiomyopathy","volume":"91","author":"Hughes","year":"2005","journal-title":"Heart"},{"key":"R34-4-20210204","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvn083","article-title":"Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy","volume":"79","author":"Birks","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R35-4-20210204","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.RES.86.8.846","article-title":"Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium","volume":"86","author":"Heling","year":"2000","journal-title":"Circ Res"},{"key":"R36-4-20210204","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/hh1301.092688","article-title":"Expression of r120g-alphab-crystallin causes aberrant desmin and alphab-crystallin aggregation and cardiomyopathy in mice","volume":"89","author":"Wang","year":"2001","journal-title":"Circ Res"},{"key":"R37-4-20210204","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.1073\/pnas.0503324102","article-title":"Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy","volume":"102","author":"Sanbe","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-4-20210204","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/01.RES.0000189262.92896.0b","article-title":"Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake","volume":"97","author":"Chen","year":"2005","journal-title":"Circ Res"},{"key":"R39-4-20210204","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.0609202104","article-title":"Exercise reverses preamyloid oligomer and prolongs survival in alphab-crystallin-based desmin-related cardiomyopathy","volume":"104","author":"Maloyan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-4-20210204","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jacc.2010.01.075","article-title":"Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy","volume":"56","author":"Zheng","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R41-4-20210204","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.05-4869fje","article-title":"Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts","volume":"20","author":"Liu","year":"2006","journal-title":"FASEB J"},{"key":"R42-4-20210204","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.yjmcc.2005.12.011","article-title":"Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes","volume":"40","author":"Liu","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R43-4-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvq217","article-title":"Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts","volume":"88","author":"Tang","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R44-4-20210204","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","article-title":"Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy","volume":"114","author":"Depre","year":"2006","journal-title":"Circulation"},{"key":"R45-4-20210204","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.107.097816","article-title":"Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system","volume":"51","author":"Meiners","year":"2008","journal-title":"Hypertension"},{"key":"R46-4-20210204","doi-asserted-by":"crossref","first-page":"H645","DOI":"10.1152\/ajpheart.00196.2007","article-title":"Proteasome inhibition promotes regression of left ventricular hypertrophy","volume":"294","author":"Stansfield","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R47-4-20210204","first-page":"190","article-title":"Inhibiting Hdm2 and ubiquitin-activating enzyme: targeting the ubiquitin conjugating system in cancer.","volume":"171-","author":"Weissman","year":"2008","journal-title":"Ernst Schering Found Symp Proc"},{"key":"R48-4-20210204","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cvr\/cvn289","article-title":"Build it up-tear it down: protein quality control in the cardiac sarcomere","volume":"81","author":"Willis","year":"2009","journal-title":"Cardiovasc Res"},{"key":"R49-4-20210204","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","article-title":"The proteasome, a novel protease regulated by multiple mechanisms","volume":"274","author":"DeMartino","year":"1999","journal-title":"J Biol Chem"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e32834598fe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:03:38Z","timestamp":1786043018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-201105000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e32834598fe","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}